CPRX
Catalyst Pharmaceuticals Inc
31.50$
+0.0%
vs. previous close
Closing price · As of: Jul 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | 1,683.4% | 13.8% | 14.8% | 14.2% | 14.6% | 14.2% | 14.0% | 13.2% | 15.7% | 15.5% | 12.5% | 14.8% | 19.2% | 13.7% | 14.4% | 16.9% | 18.4% | 11.7% | 12.1% | 13.8% | 14.3% | 12.7% | 12.6% | 15.0% | 15.3% | 12.7% | 20.4% | 17.1% | 17.1% | 16.2% | 17.7% | |
| – | – | – | – | – | – | – | – | – | – | -1,583.4% | 86.2% | 85.2% | 85.8% | 85.4% | 85.8% | 86.0% | 86.8% | 84.3% | 84.5% | 87.5% | 85.2% | 80.8% | 86.3% | 85.6% | 83.1% | 81.6% | 88.3% | 87.9% | 86.2% | 85.7% | 87.3% | 87.4% | 85.0% | 84.7% | 87.3% | 79.6% | 82.9% | 82.9% | 83.8% | 82.3% | |
| – | – | – | – | – | – | – | – | – | – | 1,683.4% | 26.6% | 16.1% | 14.9% | 20.9% | 14.5% | 14.7% | 12.8% | 13.5% | 10.0% | 12.2% | 12.5% | 13.0% | 7.9% | 7.5% | 14.5% | 6.7% | 4.2% | 4.0% | 81.5% | 1.8% | 2.6% | 2.4% | 2.6% | 2.7% | 2.7% | 3.0% | 1.8% | 1.2% | 1.8% | 1.9% | |
| – | – | – | – | – | – | – | – | – | – | 1,385.3% | 67.6% | 14.2% | 11.0% | 37.9% | 14.6% | 17.6% | 15.0% | 21.9% | 23.3% | 15.3% | 15.7% | 13.7% | 22.4% | 10.6% | 10.6% | 11.3% | 14.0% | 10.1% | 11.6% | 11.9% | 21.9% | 11.8% | 33.7% | 9.5% | 31.3% | 28.8% | 30.0% | 13.0% | 33.0% | 26.1% | |
| – | – | – | – | – | – | – | – | – | – | 3,068.7% | 94.2% | 47.2% | 41.0% | 58.8% | 49.0% | 51.3% | 46.8% | 56.5% | 52.1% | 43.9% | 46.3% | 47.6% | 46.0% | 31.8% | 39.3% | 30.9% | 46.6% | 41.0% | 122.4% | 48.0% | 59.8% | 43.2% | 45.5% | 40.4% | 42.5% | 34.3% | 38.3% | 42.4% | 34.8% | 37.5% | |
| – | – | – | – | – | – | – | – | – | – | -2,968.7% | -7.9% | 38.0% | 44.8% | 26.6% | 36.7% | 34.7% | 39.9% | 27.8% | 32.4% | 43.6% | 38.9% | 33.3% | 40.3% | 53.8% | 43.9% | 50.7% | 41.7% | 46.9% | -36.2% | 37.7% | 27.5% | 44.2% | 39.6% | 44.3% | 44.8% | 45.2% | 44.7% | 40.5% | 49.0% | 44.8% | |
| – | – | – | – | – | – | – | – | – | – | 68.7% | 2.8% | 1.6% | 1.3% | 1.3% | 1.2% | – | – | 1.1% | – | – | – | – | 0.2% | 0.6% | 1.6% | 4.6% | 2.0% | – | 0.3% | 1.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -2,899.9% | -5.2% | 39.6% | 46.1% | 27.9% | 37.9% | 35.1% | 40.0% | 28.1% | 32.7% | 43.7% | 39.1% | 33.4% | 40.5% | 53.2% | 45.4% | 54.3% | 43.7% | 48.7% | -37.0% | 42.2% | 29.5% | 45.5% | 44.5% | 52.3% | 50.4% | 47.3% | 47.9% | 47.1% | 56.4% | 49.7% | |
| – | – | – | – | – | – | – | – | – | – | -2.5% | -0.1% | 1.6% | 2.0% | 1.6% | 2.1% | 2.1% | -107.8% | -8.7% | 7.3% | 10.2% | 10.4% | 9.1% | 9.8% | 12.5% | 5.7% | 12.4% | 9.1% | 10.8% | -7.1% | 10.7% | 5.9% | 12.2% | 10.4% | 12.9% | 10.3% | 11.7% | 12.3% | 12.6% | 13.7% | 12.6% | |
| – | – | – | – | – | – | – | – | – | – | -2,899.9% | -5.2% | 38.0% | 44.1% | 26.3% | 35.8% | 33.0% | 147.8% | 36.9% | 25.4% | 33.5% | 28.7% | 24.3% | 30.7% | 40.7% | 39.7% | 41.9% | 34.6% | 37.9% | -30.0% | 31.5% | 23.6% | 33.2% | 34.1% | 39.4% | 40.1% | 35.6% | 35.6% | 34.5% | 42.7% | 37.1% | |
| – | – | – | – | – | – | – | – | – | – | -2,966.2% | -7.9% | 38.0% | 44.8% | 27.5% | 37.0% | 37.1% | 40.0% | 27.9% | 32.8% | 43.8% | 39.2% | 33.7% | 40.6% | 53.2% | 46.4% | 50.7% | 51.4% | 57.3% | -28.4% | 50.5% | 39.1% | 53.2% | 51.8% | 59.0% | 57.1% | 53.7% | 54.2% | 53.4% | 63.0% | 56.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.